Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from OncoSil Medical Ltd ( (AU:OSL) ) is now available.
OncoSil Medical Ltd announced the cessation of 12,500 securities due to the lapse of conditional rights, as the conditions for these securities were not met. This development may impact the company’s financial structure and could influence investor perceptions, although the broader implications for stakeholders remain to be seen.
The most recent analyst rating on (AU:OSL) stock is a Sell with a A$1.00 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical industry, focusing on developing and commercializing innovative medical devices. The company’s primary product is a targeted radioactive implant designed for the treatment of pancreatic cancer, aiming to improve patient outcomes in oncology.
Average Trading Volume: 23,358
Technical Sentiment Signal: Sell
Current Market Cap: A$21.65M
See more data about OSL stock on TipRanks’ Stock Analysis page.